Curosurf (poractant alfa) - Chiesi
Single-blind randomized clinical trial in premature infants with Respiratory Distress Syndrome (RDS) eligible for treatment with exogenous surfactant identified early by lung ultrasonography. (clinicaltrialsregister.eu) - May 25, 2026 - P1/2 | N=30 | Recruiting | Sponsor: Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau | Not yet recruiting ➔ Recruiting 
Enrollment open • Acute Respiratory Distress Syndrome • Respiratory Diseases
https://euclinicaltrials.eu/ctis-public/view/2024-515641-42-00
 
May 25, 2026
 
Prev Next